Results 221 to 230 of about 16,984,937 (354)
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham+21 more
wiley +1 more source
Developing and implementing an obesity medicine fellowship program: Experience at a U.S. academic medical center. [PDF]
Chaudhry ZW+3 more
europepmc +1 more source
Library to Offer New Classes Next Semester, Vol.2 (6) November - December 2004 [PDF]
Houston Academy of Medicine-Texas Medical Center Library
core +1 more source
Single‐cell transcriptomics of prostate cancer patient‐derived xenografts reveals distinct features of neuroendocrine (NE) subtypes. Tumours with focal NE differentiation (NED) share transcriptional programmes with adenocarcinoma, differing from large and small cell neuroendocrine prostate cancer (NEPC). Our work defines the molecular landscape of NEPC,
Rosalia Quezada Urban+12 more
wiley +1 more source
An infographic on laboratory animal veterinarians. [PDF]
Kim JY+22 more
europepmc +1 more source
The HAM-TMC Library Welcomes You!, Vol.21 (1) July - September 2007 [PDF]
Houston Academy of Medicine-Texas Medical Center Library
core +1 more source
Notes on Certain Cestodes in the School of Tropical Medicine, Liverpool
T. Southwell
openalex +2 more sources
Decrypting cancer's spatial code: from single cells to tissue niches
Spatial transcriptomics maps gene activity across tissues, offering powerful insights into how cancer cells are organised, switch states and interact with their surroundings. This review outlines emerging computational, artificial intelligence (AI) and geospatial approaches to define cell states, uncover tumour niches and integrate spatial data with ...
Cenk Celik+4 more
wiley +1 more source